Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Clewell

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Toxicology Letters|September 1, 1995
The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substancesH J Clewell
Toxicology|September 1, 1995
Incorporating biological information in quantitative risk assessment: an example with methylene chlorideH J Clewell
Toxicology Letters|May 1, 1993
Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testingH J Clewell
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 1, 1994
Incorporation of pharmacokinetics in noncancer risk assessment: example with chloropentafluorobenzeneH J Clewell, B M Jarnot
Toxicology and Industrial Health|January 1, 1994
Physiologically-based pharmacokinetic modeling and bioactivation of xenobioticsH J Clewell, M E Andersen
Toxicology|July 17, 1996
Use of physiologically based pharmacokinetic modeling to investigate individual versus population riskH J Clewell, M E Andersen
Health Physics|January 1, 1989
Biologically motivated models for chemical risk assessmentH J Clewell, M E Andersen
Toxicology and Industrial Health|December 1, 1985
Risk assessment extrapolations and physiological modelingH J Clewell, M E Andersen
Toxicology Letters|December 1, 1989
Improving toxicology testing protocols using computer simulationsH J Clewell, M E Andersen
Environmental Health Perspectives|May 12, 2000
Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessmentH A Barton, H J Clewell
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Toxicology Letters|September 1, 1995
The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substancesH J Clewell
Toxicology|September 1, 1995
Incorporating biological information in quantitative risk assessment: an example with methylene chlorideH J Clewell
Toxicology Letters|May 1, 1993
Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testingH J Clewell
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 1, 1994
Incorporation of pharmacokinetics in noncancer risk assessment: example with chloropentafluorobenzeneH J Clewell, B M Jarnot
Toxicology and Industrial Health|January 1, 1994
Physiologically-based pharmacokinetic modeling and bioactivation of xenobioticsH J Clewell, M E Andersen
Toxicology|July 17, 1996
Use of physiologically based pharmacokinetic modeling to investigate individual versus population riskH J Clewell, M E Andersen
Health Physics|January 1, 1989
Biologically motivated models for chemical risk assessmentH J Clewell, M E Andersen
Toxicology and Industrial Health|December 1, 1985
Risk assessment extrapolations and physiological modelingH J Clewell, M E Andersen
Toxicology Letters|December 1, 1989
Improving toxicology testing protocols using computer simulationsH J Clewell, M E Andersen
Environmental Health Perspectives|May 12, 2000
Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessmentH A Barton, H J Clewell
Pageof 7